Recombinant DNA Technology

Global Market Trajectory & Analytics

MCP22688

EXECUTIVE ENGAGEMENTS

OUTREACH

907
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

181
Interactions with Platform & by Email

PARTICIPANTS

36
Unique # Participated

VALIDATIONS

16
Responses Validated*

COMPETITORS

32
Responses Validated*

BRANDS

0
Responses Validated*
* Login for a full stack data experience

DATE

FEB 2021

TABLES

150

PAGES

212

EDITION

6

PRICE

USD $5600


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Recombinant DNA Technology estimated at US$609.8 Million in the year 2020, is projected to reach a revised size of US$841.3 Million by 2027, growing at aCAGR of 4.7% over the period 2020-2027. Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$631.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
The Recombinant DNA Technology market in the U.S. is estimated at US$179.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$148.5 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.We bring years of research experience to this 6th edition of our report. The 130-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

SELECT PLAYERS

Amgen Inc; Bamboo Therapeutics, Inc.; Biocon; Biogen; Chiron Corporation; Cibus; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech, Inc; GenScript; GlaxoSmithKline plc.; Horizon Discovery Group plc; Merck KGaA; Monsanto Company; New England Biolabs; Novartis AG; Novo Nordisk A/S; Nucelis; Pfizer Inc.; Profacgen; Sanofi; Syngene

SEGMENTS

» Product Type (Medical, Non-Medical) » Type (Expression System, Cloning Vector) » Application (Health & Disease, Food & Agriculture, Environmental, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Recombinant DNA Technology Competitor Market Share Scenario Worldwide (in %): 2020E
Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Non-Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Expression System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cloning Vector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Health & Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
Market Facts & Figures
USA Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
China Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
China Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
Europe Current & Future Analysis for Recombinant DNA Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Recombinant DNA Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
France Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
France Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 32

General queries: Info411@StrategyR.com